BBHC
BIVV

Brown Brothers Harriman & Co’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Brown Brothers Harriman & Co’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,487
Closed -$80K – 1271
2017
Q4 		$80K Sell
1,487
-35
-2% -$1.92K ﹤0.01% 463
2017
Q3 		$87K Hold
1,522
– – ﹤0.01% 423
2017
Q2 		$92K Buy
1,522
+50
+3% +$2.85K ﹤0.01% 414
2017
Q1 		$80K Buy
+1,472
New +$72.5K ﹤0.01% 441

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Brown Brothers Harriman & Co's BIVV Position: Q1 2018 in Review

Brown Brothers Harriman & Co sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,487 shares — an estimated $80K sold.

Brown Brothers Harriman & Co first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $92K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Brown Brothers Harriman & Co reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 1,487 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $80K.
  • Brown Brothers Harriman & Co first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Brown Brothers Harriman & Co's Bioverativ Inc. Common Stock position peaked at $92K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2018, filed 14 May 2018.